You are here

  • Home
  • Archive
  • Volume 76, Issue 12
  • Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies

Article info

Article menu
Download PDFPDF
Original research
Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies

Authors

  • Massimo Radin Department of Clinical and Biological Sciences, University of Turin, Turin, Italy University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK- net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital and University of Turin, Turin, Italy PubMed articlesGoogle scholar articles
  • Alice Barinotti Department of Clinical and Biological Sciences, University of Turin, Turin, Italy University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK- net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital and University of Turin, Turin, Italy PubMed articlesGoogle scholar articles
  • Irene Cecchi Department of Clinical and Biological Sciences, University of Turin, Turin, Italy University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK- net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital and University of Turin, Turin, Italy PubMed articlesGoogle scholar articles
  • Silvia Grazietta Foddai Department of Clinical and Biological Sciences, University of Turin, Turin, Italy University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK- net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital and University of Turin, Turin, Italy PubMed articlesGoogle scholar articles
  • Elena Rubini Department of Clinical and Biological Sciences, University of Turin, Turin, Italy University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK- net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital and University of Turin, Turin, Italy PubMed articlesGoogle scholar articles
  • Dario Roccatello Department of Clinical and Biological Sciences, University of Turin, Turin, Italy University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK- net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital and University of Turin, Turin, Italy PubMed articlesGoogle scholar articles
  • Elisa Menegatti Department of Clinical and Biological Sciences, University of Turin, Turin, Italy School of Specialization of Clinical Pathology, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy PubMed articlesGoogle scholar articles
  • Savino Sciascia Department of Clinical and Biological Sciences, University of Turin, Turin, Italy University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK- net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital and University of Turin, Turin, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Savino Sciascia, Department of Clinical and Biological Sciences, University of Turin, Torino 10124 TO, Italy; savino.sciascia{at}unito.it
View Full Text

Citation

Radin M, Barinotti A, Cecchi I, et al
Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies
Journal of Clinical Pathology 2023;76:839-846.

Publication history

  • Received February 2, 2022
  • Accepted August 30, 2022
  • First published September 13, 2022.
Online issue publication 
November 17, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.